TFRC and cancer: In esophageal cancer, Exo-PDL1 release from cancer cells causes an imbalance in the Tfh/Tfr (follicular helper T cells) cell ratio, promoting the expansion and suppressive functions of Tfr cells and leading to the impairment of anti-tumor T cell functions and an immunosuppressive environment [43].